These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16797858)

  • 21. Identification of putative zinc hydrolase genes of the metallo-beta-lactamase superfamily from Campylobacter jejuni.
    Alfredson DA; Korolik V
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):159-64. PubMed ID: 17266723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metal content and localization during turnover in B. cereus metallo-beta-lactamase.
    Llarrull LI; Tioni MF; Vila AJ
    J Am Chem Soc; 2008 Nov; 130(47):15842-51. PubMed ID: 18980306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the chemistry of penicillin as a beta-lactamase-dependent prodrug.
    Ruddle CC; Smyth TP
    Org Biomol Chem; 2007 Jan; 5(1):160-8. PubMed ID: 17164921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.
    Both GW
    Curr Opin Mol Ther; 2009 Aug; 11(4):421-32. PubMed ID: 19649987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2.
    Mitchell DJ; Minchin RF
    Cancer Gene Ther; 2008 Nov; 15(11):758-64. PubMed ID: 18600257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's new in antibiotic resistance? Focus on beta-lactamases.
    Babic M; Hujer AM; Bonomo RA
    Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
    Deshpande LM; Jones RN; Fritsche TR; Sader HS
    Int J Antimicrob Agents; 2006 Dec; 28(6):578-81. PubMed ID: 17112706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing.
    Espedido BA; Thomas LC; Iredell JR
    J Clin Microbiol; 2007 Jun; 45(6):2034-6. PubMed ID: 17409217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
    Pastorakova A; Hlubinova K; Altaner C
    Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions.
    Wang JJ; Sung KC; Yeh CH; Fang JY
    Int J Pharm; 2008 Apr; 353(1-2):95-104. PubMed ID: 18158222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered erythrocytes as carriers and bioreactors.
    De Flora A; Tonetti M; Zocchi E; Guida L; Polvani C; Gasparini A; Benatti U
    Year Immunol; 1993; 7():168-74. PubMed ID: 8372505
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of plasmid-mediated class C beta-lactamases.
    Doi Y; Paterson DL
    Int J Infect Dis; 2007 May; 11(3):191-7. PubMed ID: 17339123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads.
    Bourgeois S; Gernet M; Pradeau D; Andremont A; Fattal E
    Int J Pharm; 2006 Oct; 324(1):2-9. PubMed ID: 16822628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overproduction of a metallo-beta-lactamase by a strong promoter causes high-level imipenem resistance in a clinical isolate of Pseudomonas aeruginosa.
    Takeda S; Nakai T; Ikeda F; Hatano K
    Chemotherapy; 2008; 54(3):181-7. PubMed ID: 18560224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.